Elderly patients in care homes across Scotland are being prescribed
powerful drugs for long periods of time without proper checks on whether
the medication is needed. In some cases, frail patients are
being kept on multiple and potentially harmful doses for up to two
decades without doctors or staff questioning whether they are necessary. Patients are often kept on a mix of drugs for health problems that may have resolved over time.
The Royal Pharmaceutical Society in Scotland (RPSS) in a report calls for more powers for pharmacists to review patients’ medical records. Pharmacists say they are becoming “increasingly concerned” about patients’ safety.
Drugs regularly handed out to elderly patients include anti-psychotic medicines for dementia. These are classed as high-risk because of their links to heart problems and strokes, yet some patients remain on these far longer than is required. Other drugs could be causing drowsiness and dizziness, leading to falls and loss of appetite.
Henry Simmons, chief executive of Alzheimer Scotland, said: “The dangers of inappropriate or long-term prescribing without regular review are clear: an increase in falls due to dizziness and unsteadiness, an almost doubling of mortality rates and double the risk of stroke in people with dementia.”
The Royal Pharmaceutical Society in Scotland (RPSS) in a report calls for more powers for pharmacists to review patients’ medical records. Pharmacists say they are becoming “increasingly concerned” about patients’ safety.
Drugs regularly handed out to elderly patients include anti-psychotic medicines for dementia. These are classed as high-risk because of their links to heart problems and strokes, yet some patients remain on these far longer than is required. Other drugs could be causing drowsiness and dizziness, leading to falls and loss of appetite.
Henry Simmons, chief executive of Alzheimer Scotland, said: “The dangers of inappropriate or long-term prescribing without regular review are clear: an increase in falls due to dizziness and unsteadiness, an almost doubling of mortality rates and double the risk of stroke in people with dementia.”